(Q37872232)

24 August 2017

1 reference

title

Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease (English)

1 reference

24 August 2017

1 reference

1 reference

Alex Tsui

1

1 reference

24 August 2017

Ole Isacson

series ordinal

2

1 reference

24 August 2017

language of work or name

1 reference

5 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

258

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

1393-1405

1 reference

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Robust pacemaking in substantia nigra dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Calcium, ageing, and neuronal vulnerability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Profound neuronal plasticity in response to inactivation of the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Molecular analysis of the multiple Golf alpha subunit mRNAs in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

DARPP-32: an integrator of neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Striatal synaptic plasticity: implications for motor learning and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Presynaptic mechanisms of motor complications in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Corticostriatal LTP requires combined mGluR1 and mGluR5 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Selective involvement of mGlu1 receptors in corticostriatal LTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Postsynaptic signaling and plasticity mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Levodopa response motor complications--GABA receptors and preproenkephalin expression in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Assessing fetal nerve cell grafts in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

The production and use of cells as therapeutic agents in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

The Cerebellum and Basal Ganglia are Interconnected

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

The pedunculopontine nucleus and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6061-6

Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo

21 January 2018

1 reference

12 December 2020

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

1 reference

12 December 2020

L-dopa therapy for Parkinson's disease: past, present, and future

1 reference

12 December 2020

A complex program of striatal gene expression induced by dopaminergic stimulation.

1 reference

12 December 2020

Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon

1 reference

12 December 2020

Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity

1 reference

12 December 2020

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

1 reference

12 December 2020

Long-term delayed vascularization of human neural transplants to the rat brain.

1 reference

12 December 2020

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

1 reference

12 December 2020

Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration.

1 reference

12 December 2020

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

1 reference

12 December 2020

Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones

1 reference

12 December 2020

10.1007/S00415-011-6061-6

Identifiers

DOI

1 reference

24 August 2017

1 reference